Creatine vs Beta-Alanine — same shelf, very different jobs
Creatine and beta-alanine sit next to each other in every pre-workout aisle, and consumers regularly treat them as interchangeable "performance supplements." They are not. Creatine works almost entirely in the 0–10 second, high-power, ATP-replenishment window. Beta-alanine works almost entirely in the 1–4 minute window where intramuscular acidosis becomes the rate-limiting step. They solve different bioenergetic problems for different training modalities — and unlike most supplement pairings, the two stack cleanly because they don't fight for the same mechanism.
Quick verdict
| Goal | Better choice | Why |
|---|---|---|
| Strength & powerlifting (1–5 rep work) | Creatine | The trial evidence is overwhelming for 1RM and short-duration power; beta-alanine has no meaningful signal at these durations. |
| Hypertrophy / bodybuilding | Creatine | Indirect benefit via more total volume tolerated, plus an osmotic / signalling effect on muscle. Beta-alanine helps only at higher rep-range protocols. |
| Sprint cycling, 400–1500m running, CrossFit, MMA conditioning | Beta-alanine | This is exactly its 1–4 minute window. Meta-analyses show small but consistent improvements; creatine helps less here. |
| Endurance events >25 minutes | Neither (small beta-alanine signal) | Both have weak or null evidence for long endurance. Beta-alanine has a marginal signal for late-race kicks. |
| Combat sports / fight prep | Both stacked | Strength + high-intensity repeated efforts both matter; the two stack with no antagonism. |
| Cognitive / non-athletic adults | Creatine | Emerging trial evidence for sleep-deprived cognition, mood adjuncts, and possibly age-related cognitive decline. Beta-alanine has no off-target use case. |
How they compare on the things that matter
Mechanism — different bioenergetic windows
Creatine raises intramuscular phosphocreatine stores, which buffer ATP during the first 0–10 seconds of all-out effort. The biochemical signal is unambiguous: a 4-week loading protocol raises muscle phosphocreatine by 10–20%, and that translates into more total work in single explosive sets. The cellular hydration and possible direct signalling effects on muscle satellite cells appear to contribute to the hypertrophy benefit.
Beta-alanine is the rate-limiting precursor for carnosine — an intramuscular pH buffer. Loading beta-alanine for 4–10 weeks raises intramuscular carnosine by 40–80%, which lets the muscle delay acidosis-driven fatigue when efforts last 1–4 minutes. This is why beta-alanine doesn't help a one-rep max squat (acidosis isn't the limiter) and doesn't help a marathon (the buffering capacity gain is irrelevant at submaximal aerobic intensities).
Evidence base by endpoint
- Strength / 1RM: Creatine has dozens of positive RCTs and multiple meta-analyses. Effect size is small-to-moderate but reliably reproduced. Beta-alanine has essentially no 1RM signal.
- Muscle mass: Creatine has meta-analytic support (Burke 2024, Xu 2024) for additional ~1–2 kg of lean mass over training alone across 8–12 weeks. Beta-alanine has no reliable hypertrophy signal.
- High-intensity exercise 1–4 minutes: Beta-alanine has meta-analytic support (Saunders 2017, Pulido-Folch 2025) for small but consistent improvements. Creatine's signal here is weaker.
- Repeated sprint ability: Both help — creatine more for the first repeats (ATP recovery between bouts), beta-alanine more as the bout count rises and acidosis accumulates.
- Cognition and non-athletic uses: Creatine has emerging RCT evidence in sleep-deprived cognition, depressive symptoms as an adjunct, and ageing-related cognition (Forbes 2022). Beta-alanine has none.
- Safety profile: Both have long-running ISSN safety reviews supporting use at standard doses.
Dose and form
Creatine monohydrate at 3–5 g/day produces full muscle saturation within ~28 days; a 20 g/day load for 5 days reaches the same endpoint faster but offers no advantage long-term. Creatine HCl, ethyl ester, and other "advanced" forms have no demonstrated benefit over monohydrate and cost more per gram of delivered creatine.
Beta-alanine at 4–6 g/day, divided into 0.8–1.6 g doses to manage paresthesia, for 4–10 weeks. Sustained-release formulations reduce the tingling but cost more. The full effect requires consistent daily dosing — you can't take it pre-workout only and expect the buffering benefit.
Safety and side effects
Creatine is one of the most safety-characterised supplements in the literature. The historical kidney-injury concern has not been borne out across long-running cohorts in healthy adults; people with pre-existing renal disease should still discuss with a clinician. Some users gain 1–2 kg of water weight in the first weeks, which is real but cosmetic.
Beta-alanine's signature side effect is paresthesia — a harmless tingling on the skin (face, neck, hands) that starts ~15 minutes after dosing and resolves within an hour. It's not dangerous, but it's why splitting doses or using sustained-release forms exists. There is no other notable safety signal at trial-cited doses.
What the price difference buys you
Both are cheap when bought as plain powders. Creatine monohydrate costs roughly $0.10–0.20 per 5 g serving; beta-alanine costs roughly $0.15–0.30 per 3 g serving. The cost trap on both is pre-workout blends that include sub-therapeutic doses of each (often 1.5 g creatine, 1.5 g beta-alanine per scoop), which is enough to give you the beta-alanine tingle but not enough of either to deliver the trial-grade effect.
Who should skip each
Creatine is generally well tolerated but should be approached cautiously with pre-existing kidney disease or with concomitant nephrotoxic medications. Adequate hydration matters; people on restrictive fluid intake regimens should discuss with a clinician before loading.
Beta-alanine should be approached cautiously in anyone who finds the paresthesia unpleasant enough that adherence will be poor — adherence is the dominant predictor of effect. There are no major drug interactions. Pregnancy and lactation safety data are insufficient.
What we'd actually buy
For a strength-focused lifter: creatine monohydrate 5 g/day, any time of day, with food. Skip the loading phase — you reach saturation in 28 days regardless.
For a CrossFit, sprint-cycling, or combat-sports athlete: beta-alanine 4 g/day split into 1 g doses across the day, for 8 weeks, alongside training. Sustained-release if the tingling is intolerable.
For an athlete whose sport spans both windows (rugby, MMA, hockey, field sports): stack them. 5 g creatine monohydrate + 4 g beta-alanine daily. They don't interact at the mechanism level.
Sources
- Kreider RB, et al. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. J Int Soc Sports Nutr. 2017;14:18. PMID: 28615996
- Trexler ET, et al. International society of sports nutrition position stand: Beta-Alanine. J Int Soc Sports Nutr. 2015;12:30. PMID: 26175657
- Saunders B, et al. β-alanine supplementation to improve exercise capacity and performance: a systematic review and meta-analysis. Br J Sports Med. 2017;51(8):658–669. PMID: 27797728
- Forbes SC, et al. Creatine supplementation and brain health. Nutrients. 2022;14(5):921. PMID: 35267907
- Xu C, et al. The effect of creatine supplementation on lean body mass with and without resistance training. Nutrients. 2024;16(13):2103. PMID: 39070254
- Hobson RM, et al. Effects of β-alanine supplementation on exercise performance: a meta-analysis. Amino Acids. 2012;43(1):25–37. PMID: 22270875